http://orcid.org/0000-0002-6820-3862
References
- Michall M. Allogreffes de cellules souches hématopoïétiques. Transfus Clin Biol. 2011;18(2):1–5.
- Majhail NS, Mothukuri JM, Brunstein CG, et al. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biol Blood Marrow Transplant. 2009;15(5):564–573. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19361748
- Spring L, Li S, Soiffer RJ, et al. Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival. Biol Blood Marrow Transplant. 2015;21(3):509–516. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25482866
- Leelahavarong P, Chaikledkaew U, Hongeng S, et al. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Serv Res. 2010;10(1):209. Available from: http://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-10-209
- Khera N, Zeliadt SB, Lee SJ. Economics of hematopoietic cell transplantation. Blood. 2012;120(8):1545–1551. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22700725
- Chen XH, Zhang C, Zhang X, et al. Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies. Transfus Apher Sci. 2010;43(1):23–28. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20554478
- Svahn BM, Remberger M, Alvin O, et al. Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation. Bone Marrow Transplant. 2012;47(5):706–715. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21874063
- Mishra V, Vaaler S, Brinch L. A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures. Bone Marrow Transplant. 2001 Dec;28(12):1111–1116. Available from: https://www.ncbi.nlm.nih.gov/pubmed/11803351
- Segondy M. Infections virales chez les patients transplantés. Revue francophone des laboratoires. 2008;38(403):31–40. Available from: http://www.sciencedirect.com/science/article/pii/S1773035X08733331
- Parody R, Martino R, Rovira M, et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant. 2006;12(7):734–748. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16785063
- Dazzi F, Fozza C. Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment. Best Pract Res Clin Haematol. 2007;20(2):311–727. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17448964
- Lin YF, Lairson DR, Chan W, et al. The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia. Biol Blood Marrow Transplant. 2010;16(9):1272–1281.